LCD (200+50) Tablet

LCD (200+50) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Intas Pharmaceuticals Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Levodopa, Carbidopa. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 75 (arround $1.05 US Dollar)

Generic (Salt) Combination :	(Levodopa+ Carbidopa)
Pharma Company :	Intas Pharmaceuticals Ltd.
Brand Label :	LCD (200+50)
Preparation Type :	Tablet
Single Dose :	1 Tablet
Composition (Fixed-Dose Combination) :	Carbidopa-50 mg Levodopa-200 mg
Pack Size/Qty/Vol :	10 Tablet
Price Unit :	Rs 7.5 INR (arround $0.105 US Dollar)
Price Pack :	Rs 75 INR (arround $1.05 US Dollar)

Drug details for LCD (200+50)

Usage: Why is this medication prescribed?

The main active ingredients or salts in LCD (200+50) are :

Carbidopa-50 mg
Levodopa-200 mg

Levodopa
Indication (Prescribed for or used as): Idiopathic, post-encephalitis and arteriosclerotic Parkinsonism.

For more details on Levodopa, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Levodopa..

Carbidopa
Indication (Prescribed for or used as): In combination with levodopa used in the management of Parkinsons disease. Levodopa combination is also used for the treatment of restless leg syndrome.

For more details on Carbidopa, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Carbidopa..

LCD (200+50) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :

There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for LCD (200+50), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Carbidopa-50 mg Levodopa-200 mg).
Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.

Brand

Price (Rs.)